According to Dr. Reddy's's latest financial reports the company's current EPS (TTM) is $2.38. In 2021 the company made an earnings per share (EPS) of $2.29 an increase over its 2020 EPS that were of $1.71.
Year | EPS | Change |
---|---|---|
2022 (TTM) | $2.38 | 3.53% |
2021 | $2.29 | 34.07% |
2020 | $1.71 | 21.35% |
2019 | $1.41 | -7.09% |
2018 | $1.52 | 64.12% |
2017 | $0.93 | 7.5% |
2016 | $0.86 | -61.17% |
2015 | $2.22 | 5.97% |
2014 | $2.09 | -5.38% |
2013 | $2.21 | 36.8% |
2012 | $1.62 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $9.79 | 312.06% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $5.31 | 123.50% | ๐บ๐ธ USA |
![]() Sanofi SNY | $3.30 | 38.78% | ๐ซ๐ท France |
![]() GlaxoSmithKline GSK | $8.30 | 249.33% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | -$1.16 | -148.82% | ๐ฎ๐ฑ Israel |